[PDF][PDF] Diagnosis and treatment of alcohol use disorder in patients with end‐stage alcoholic liver disease

F Caputo, M Domenicali, M Bernardi - Hepatology, 2019 - Wiley Online Library
Between 14%‐30% of the world's population is affected by alcohol use disorder (AUD), and
excessive alcohol consumption represents the most common cause of liver disease in the …

Integrated care of alcohol-related liver disease

GS Winder, AC Fernandez, JL Mellinger - Journal of Clinical and …, 2022 - Elsevier
Background/Aims Alcohol-related liver disease (ALD) is the medical manifestation of alcohol
use disorder, a prevalent psychiatric condition. Acute and chronic manifestations of ALD …

Assessing motivations for nonprescribed buprenorphine use among rural Appalachian substance users

MJ McDonald, AM DeVeaugh-Geiss… - Journal of Addiction …, 2023 - journals.lww.com
Objective Buprenorphine (Suboxone) is an effective treatment for opioid use disorder (OUD).
However, there have been widespread reports of diversion and misuse. This study …

Using machine learning to predict treatment adherence in patients on medication for opioid use disorder

AJ Burgess-Hull, C Brooks, DH Epstein… - Journal of Addiction …, 2023 - journals.lww.com
Objective Patients receiving medication for opioid use disorder (MOUD) may continue using
nonprescribed drugs or have trouble with medication adherence, and it is difficult to predict …

Protocol design and implementation for monitoring parental substance use in child custody litigation

CJ Weiss - Family Court Review, 2021 - Wiley Online Library
In child custody litigation, protecting child safety during access with a parent with substance
use disorder (SUD) presents a vexing challenge for the court, parents, and parents' counsel …

Direct-To-Definitive Urine and Oral Fluid Test Results for Unscreened and Rarely Screened Drugs in Individuals Applying for Methadone Treatment in 7 US States

MJ Lee-Easton, S Magura, R Abu-Obaid… - Journal of …, 2024 - Taylor & Francis
The standard protocol in addiction treatment/pain management is to conduct immunoassay
screens for major drugs subject to misuse, followed by confirmatory testing of positive …

Integrating social determinants of health and laboratory data: a pilot study to evaluate co-use of opioids and benzodiazepines

JS Warrington, N Lovejoy, J Brandon… - Academic …, 2019 - journals.sagepub.com
As the opioid crisis continues to have devastating consequences for our communities,
families, and patients, innovative approaches are necessary to augment clinical care and …

A protocol for the integration of multi-omics bioinformatics: Mechanism of acupuncture as an adjunctive therapy for alcohol use disorder

P Zhang, X Lan, B Fan, Y Chen, X Wei, X Li… - Frontiers in …, 2023 - frontiersin.org
Background Alcohol use disorder (AUD) has become a significant global factor in various
diseases. As a non-pharmacological therapy, certain therapeutic potential has been found in …

Opioid Use Disorder and Associated Infectious Disease: The Role of the Laboratory in Addressing Health Disparities

CW Farnsworth, M Lloyd, S Jean - The journal of applied …, 2021 - academic.oup.com
Background Opioid use disorder, defined as a pattern of problematic opioid use leading to
clinically significant impairment, has resulted in considerable morbidity and mortality …

Naltrexone and its noroxymorphone minor metabolite–a case report

CN Stanciu, S Gnanasegaram - Journal of Psychoactive Drugs, 2020 - Taylor & Francis
As part of substance use maintenance programs, individuals are monitored for sobriety
through urine drug screens. A positive screen, and its confirmation and interpretation, can …